ArticleImmunotherapy advances2025

A phase 1 experimental medicine study of anti-CD3 monoclonal antibody in rheumatoid arthritis.

Catherine A Lawson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.